1. Aptamer sequences used in this work.
Aptamer sequences used in this work.

Insulin binding aptamer（IBA）: 5'-GGT GGT GGG GGG GGT TGG TAG GGT GTC TTC-FAM-3'
Preparation of graphene oxide.
Graphene oxide(GO) was synthesized from natural graphite powder following literature added to the mixture, and the color of the mixture changed into brilliant yellow along with bubbling. The mixture was centrifuged and washed with 1 L 1:10 HCl aqueous solution to remove metal ions followed by 1 L DI water to remove the acid. The resulting solid was dried in air and diluted to make a GO dispersion (0.5% w/w). Finally, it was purified by dialysis for one week to remove the remaining metal species.
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Exfoliation was carried out by sonicating GO (2 mg/mL) dispersion under ambient conditions for 5 hours. The resulting sample was centrifuged at 12000 rpm for 10 min, and the upper solution was collected for future experiments.
3. Fluorescence response of 1:1 aptamer-based assay towards Insulin.
FAM-labeled insulin aptamer was diluted to 100nM in insulin buffer (50mM Tris-HCl, 10mM KCl, 100mM NaCl). An aliquot of the GO suspension (about 0.5 mg/mL) was added to the working solution (ratio of DNA and GO was 1nmol DNA to 1mg GO) and allowed to incubate for 30 min at room temperature to quench the fluorescence. Afterwards, 4-(1-pyrenyl) butyric acid (PBA) (3 μL, 100 μM) was added to the mixture solution as a surface-blocking agent. Then, different amounts of insulin were added into the GO-aptamer solution and incubated for 2 hours. The final concentration of insulin ranged from 5nM to 50μM. Finally the fluorescence intensities of the GO-aptamer complex were detected.
Fluorescence response of amplified aptamer-based assay towards Insulin.
FAM-labeled insulin aptamer was diluted to 100nM in insulin buffer (50mM Tris-HCl, 10mM KCl, 100mM NaCl). An aliquot of the GO suspension (about 0.5 mg/mL) was added to the working solution and allowed to incubate for 30 min at room temperature to quench the fluorescence. Afterwards, 4-(1-pyrenyl) butyric acid (PBA) (3 μL, 100 μM) was added to the mixture solution as a surface-blocking agent. Then, DNase I (25U) and different amounts of insulin were added to the GO-aptamer solution and incubated for 2 hours. The final concentration of insulin ranged from 5nM to 50μM. Finally the fluorescence intensities of the GO-aptamer complex were detected.
